GO
Loading...

Pharma Has Recovered From the 'Patent Cliff'

Sunday, 26 May 2013 | 10:52 PM ET

Peter Wilmshurst, Portfolio Manager, Templeton Global Equity Group at Franklin Templeton Investments tells CNBC's Cash Flow why he likes pharmaceutical stocks at the moment.